Innovex director receives 5,465-share stock grant

Innovex International, Inc. director Benjamin Matthew Fink reported an equity award of common stock.

Accepted by SEC EDGAR 03/03/2026 - 07:00 PM EST

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Innovex International, Inc. director Benjamin Matthew Fink reported an equity award of common stock. He acquired 5,465 shares of common stock on a grant/award basis at a stated price of $0.00 per share. Following this award, his directly held common stock position increased to 21,376 shares.

Insider Trade Summary

Grant/Award: 5,465 shares

Grant/Award 1 txn

Insider Fink Benjamin Matthew

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	5,465	$0.00	$0.00

Holdings After Transaction: Common Stock — 21,376 shares (Direct)

Holdings Before and After: Common Stock, 15,911 to 21,376 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Innovex (INVX) report for Benjamin Matthew Fink?

Innovex director Benjamin Matthew Fink reported receiving a grant of 5,465 shares of common stock. The award was recorded at a price of $0.00 per share, increasing his directly held stake to 21,376 shares after the transaction.

Was the Innovex (INVX) Form 4 transaction a purchase or a grant?

The Innovex Form 4 shows a grant or award acquisition, not an open-market purchase. Code “A” designates a grant, award, or other acquisition, with 5,465 common shares added to Benjamin Matthew Fink’s directly held position at a stated price of $0.00.

How many Innovex (INVX) shares does Benjamin Matthew Fink hold after this Form 4?

After receiving the equity grant, Benjamin Matthew Fink holds 21,376 shares of Innovex common stock directly. This total includes the 5,465 shares reported as acquired through the grant transaction dated February 27, 2026, under transaction code “A.”

What does transaction code “A” mean in the Innovex (INVX) Form 4 filing?

Transaction code “A” in the Innovex Form 4 indicates a grant, award, or other acquisition of securities. In this case, it reflects 5,465 common shares granted to director Benjamin Matthew Fink at a stated price of $0.00 per share, increasing his direct holdings.

Is the Innovex (INVX) insider transaction classified as direct or indirect ownership?

The Innovex insider transaction is classified as direct ownership. The Form 4 indicates “D” for direct, meaning the 5,465 granted shares and the resulting 21,376 total shares are held directly by Benjamin Matthew Fink rather than through an intermediary entity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fink Benjamin Matthew

(Last)

(First)

(Middle)

19120 KENSWICK DR.

(Street)

HUMBLE

77338

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Innovex International, Inc. [ INVX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/27/2026		A		5,465	A	$0	21,376	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

	/s/ Matt Steinheider, Attorney-in-Fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR